Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Weiser

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Translational Oncology|May 11, 2021
XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkBBasia Galinski, Marcus Luxemburg, Yosef Landesman, et al.
Sarcoma|January 25, 2021
Survey of Paediatric Oncologists and Pathologists regarding Their Views and Experiences with Variant Translocations in Ewing and Ewing-Like Sarcoma: A Report of the Children's Oncology GroupMichael D Kinnaman, Chong Zhu, Daniel A Weiser, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|April 20, 2017
Advancing Clinicopathologic Diagnosis of High-risk Neuroblastoma Using Computerized Image Analysis and Proteomic ProfilingM Khalid Khan Niazi, Jonathan H Chung, Katherine J Heaton-Johnson, et al.
Oncotarget|March 22, 2018
Detection of circulating tumor DNA in patients with osteosarcomaDavid M Barris, Shoshana B Weiner, Robert A Dubin, et al.
Cancer Medicine|September 24, 2022
A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundationJonathan L Metts, Matteo Trucco, Daniel A Weiser, et al.
Cancer Cell|December 18, 2014
ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastomaScott C Bresler, Daniel A Weiser, Peter J Huwe, et al.
Stem Cell Research|December 31, 2021
Donor-derived vasculature is required to support neocortical cell grafts after strokeJoanna Krzyspiak, Jingqi Yan, Hiyaa S Ghosh, et al.
Stem Cell Research|February 8, 2022
Corrigendum to "Donor-derived vasculature is required to support neocortical cell grafts after stroke" [59 (2022) 102642]Joanna Krzyspiak, Jingqi Yan, Hiyaa S Ghosh, et al.
Translational Oncology|July 6, 2020
Skp2 depletion reduces tumor-initiating properties and promotes apoptosis in synovial sarcomaJichuan Wang, Kenji Sato, Ed O'Donnell, et al.
Communications Medicine|January 22, 2026
Introducing iCatalog as a clinical decision support tool for collaborative pediatric precision oncology studiesWenjun Kang, Lorena Lazo de la Vega, Hannah Comeau, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Translational Oncology|May 11, 2021
XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkBBasia Galinski, Marcus Luxemburg, Yosef Landesman, et al.
Sarcoma|January 25, 2021
Survey of Paediatric Oncologists and Pathologists regarding Their Views and Experiences with Variant Translocations in Ewing and Ewing-Like Sarcoma: A Report of the Children's Oncology GroupMichael D Kinnaman, Chong Zhu, Daniel A Weiser, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|April 20, 2017
Advancing Clinicopathologic Diagnosis of High-risk Neuroblastoma Using Computerized Image Analysis and Proteomic ProfilingM Khalid Khan Niazi, Jonathan H Chung, Katherine J Heaton-Johnson, et al.
Oncotarget|March 22, 2018
Detection of circulating tumor DNA in patients with osteosarcomaDavid M Barris, Shoshana B Weiner, Robert A Dubin, et al.
Cancer Medicine|September 24, 2022
A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundationJonathan L Metts, Matteo Trucco, Daniel A Weiser, et al.
Cancer Cell|December 18, 2014
ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastomaScott C Bresler, Daniel A Weiser, Peter J Huwe, et al.
Stem Cell Research|December 31, 2021
Donor-derived vasculature is required to support neocortical cell grafts after strokeJoanna Krzyspiak, Jingqi Yan, Hiyaa S Ghosh, et al.
Stem Cell Research|February 8, 2022
Corrigendum to "Donor-derived vasculature is required to support neocortical cell grafts after stroke" [59 (2022) 102642]Joanna Krzyspiak, Jingqi Yan, Hiyaa S Ghosh, et al.
Translational Oncology|July 6, 2020
Skp2 depletion reduces tumor-initiating properties and promotes apoptosis in synovial sarcomaJichuan Wang, Kenji Sato, Ed O'Donnell, et al.
Communications Medicine|January 22, 2026
Introducing iCatalog as a clinical decision support tool for collaborative pediatric precision oncology studiesWenjun Kang, Lorena Lazo de la Vega, Hannah Comeau, et al.
Pageof 4